Department of Urology, Massachusetts General Hospital, Harvard Medical School Boston, MA.
Division of Kidney, Urologic and Hematologic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.
Urology. 2022 Aug;166:29-38. doi: 10.1016/j.urology.2021.10.008. Epub 2021 Oct 22.
To provide a scoping review of the economic burden of non-cancerous genitourinary conditions (NCGUC).
A scoping review of the economic costs associated with NCGUC was conducted for literature published between 1990-2020. The articles were screened and relevant articles were selected for review. These articles were abstracted with information pertaining to the costs surrounding NCGUC. A descriptive analysis of the data was conducted.
We found 3,298 articles in our scoping review. Of these, we found 39 relevant articles related to pelvic floor dysfunction and pelvic organ prolapse, interstitial cystitis, neurogenic bladder, nocturia, urinary tract infections, urolithiasis, urinary incontinence, benign prostatic hyperplasia, overactive bladder, and erectile dysfunction of which the data was reviewed.
Although the data in estimating the economic burden is limited, existing evidence demonstrates a significant component of health care spending on NCGUC. Much of the spending is out-of-pocket and indirect costs that are difficult to measure which may increase the magnitude of the costs. There is a need for future research that takes a holistic look at the economic impact of NCGUC.
对非癌症性泌尿生殖系统疾病（NCGUC）的经济负担进行范围综述。
对 1990 年至 2020 年间发表的与 NCGUC 相关经济成本的文献进行范围综述。对文章进行筛选，并选择相关文章进行综述。这些文章被摘录，其中包含与 NCGUC 相关成本的信息。对数据进行描述性分析。
我们在范围综述中发现了 3298 篇文章。其中，我们发现了 39 篇与盆底功能障碍和盆腔器官脱垂、间质性膀胱炎、神经源性膀胱、夜尿症、尿路感染、尿路结石、尿失禁、良性前列腺增生、膀胱过度活动症和勃起功能障碍相关的文章，对这些文章的数据进行了综述。
尽管用于估计经济负担的数据有限，但现有证据表明，NCGUC 的医疗保健支出中有相当大的一部分。大部分支出是难以衡量的自付和间接成本，这可能会增加成本的规模。需要进行未来的研究，全面评估 NCGUC 的经济影响。
